OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

THE NEURO THERAPY PLACE (Fomierly COMPASS THERAPY SUPPORT COMMUNITY LIMITED) FOR THE YEAR ENDED 310ECEMBER 2025 Charlty NumberSC014991

THE NEURO THERAPY PLACE ANNUAL REPORT OFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 Charlty Number SC014991 THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 The Trustees are pleased to present their annual Trustee5' report together wlth the financial statements of the Charity for the year ended 31 December 2025. The financlal statements have been prepared in accordance with the actounting policies set out in note I to the financial statements and comply with the charltys constitution, the Charities and Trustee Investment (Scotlandl Act 2005. the Charities Accounts (Scotlandl Regulations 2006 las amended), and Accounting and Reporting by Charities.. Statement of Recommended Practice applicable In the UK and Republic of Ireland IFRS1021 leffective l January 20191. Our vision Is to be a leading centre where personallsed therapy and wellbeing support enable5 people with neLJrologieal condition5 to thrive and live l￿fe on their own terms. Our mission is to support people with neurological condltions by providing accessible, affordable therapies that improve wellbeSng, quality of life, and connection withln our community. The organisation5 objects and principal actlvities are.. To provide co-ordinated, holistic and person-centred therapy, support and advlce to people living with long-term neurological conditlons, and to their families and carers, helplng them to addre55 the physical and emotional challenges they face. To work alongslde people living with long-term neurologlcal condltlons, actively involving them Sn declslons that affect their lives, and supportlng their confidence, independence 2nd abllity to make informed choices. To improve the physlcal, mental, emotional and soclal health and wellbeing of people living wlth long-term neurological conditions, enabling them to reach their potentlal and participate attively In thelr communitie5. To provlde therapy 5ervice5 to people with other long- or short-term health condltlons where there is a clear benefit and sufficient capacity to do so. iv. The main activities employed to asslst The Neuro Therapy Place in meetlng Its objective5 in 2025 included the following.. Provision of a facility that offers Information, advice and wellbeing support to help people living with neurological and other long-term conditions, and their families and carers, to manage their lives. Specialist I:1 neurological physiotherapy and l.'I neurological rehabilitation Service for people 1Sving with neurological condltions and other long-term conditions. Adapted speclallsed exercise (physical activltyl classes are offered to people living wlth neurological conditions and other long.term conditions. Complementary therapies including acupuntture, reflexology, massage and myofasclal release service5. Oxygen therapy 15 available to people living with neurological condition5, Other long-term health condition5 and a wide range of other condition5.

THE NEURO THEIiAPY PLACE ANNUAL REPORT OF THE BOARD OFTRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 Change5 to the Board of Trustees At our AGM on 18 June 2025, DanSel Balgrie was re-elected to the Board of Trustees. On 13th May 2025, Carole Macartney conf1rmed to the board that she would be stepping down as a Trustee at the AGM. The current Trustees would Ilke to thank Carole for her time, skills, expertise and dedication over the years. The current Trustees would like to thank everyone fortheir contributions, commltment all the hard work that they have put into The Neuro Therapy Pla￿. The Charity is grateful to have an enthusiastic and hard-working team of individuals with relevant and complementing professional skill sets. Working in partnership with the staff, all Board meetings are attended by the CEO, providing operational and strategit quarterly report5. Although not part of the board, Service user Professor Catherine Heyman Is The Neuro Therapy Place'5 patron and representative. Conversion to a SCIO What was "Comp35s Therapy Support Communlty Limited" is now a Scottish Charitable Incorporated Organisation ISCIOI, registered with the Office of the Scottish Charity Regulator IOSCRI, charlty number SC014991. The charity was formerly a limited cornpany by guarantee and converted to SCIO status on 5 November 2025. The governing document is the SCIO Constitution adopted on that date. The organisation 15 managed by a Board of Trustees, who have overall responsibility for its governance, strategic direction, and compliance with charity low and the constitution. Change of Name Part of this conversion to a SCIO allowed the organisation to formally adopted Its new name. The Neuro Therapy Place. These changes represent a slgnificant milestone in our development, strengthening the charity'$ governance, identity, and long-term sUStaln3bility. As a membership organi53tion, both the transition to a SCIO and the adoption of the new name were voted on and approved by our rnembers. The decislon to become a SCIO followed detailed conslderation by the CEO and Board, supported by professlonal advice. The SCIO Structure offers a modern and efficient framework for governance, with clearer accountability for trustees and simplified reporting to the Scottish Charity Regulator IOSCRI. Thls transltion provide5 a more resilient and transparent platform to guide the char￿t¥S next phase of development. As part of this process, the Trustees also undertook a cornprehensive review of the charitVs publlc identity and name. The previous narne, Composs Therapy Support Community limited, was re¢ognised among existing cllents. However, consultation with stakeholders and external partners highllghted that it did not clearly convey the nature of our Services neurological rehabilitation and Oxygen therapy and could cause confusion with othèr similarly named organisations In the lotal area. To ensure any change wa5 evidence based and collaborative, a working group was formed, comprising trustees, staff, and service users, with input from marketing professionals. External feedback wa5 also sought from individuals unfamiliar with the organisation to test understanding and accessibility. Following this process, The Neuro Therapy Place emerged as the most effective and representative name. The new name clearly communicates our core purpose whlle remalning approachable and memorable. It better reflects the servlces we provide, strenBthens our vlsibility among healthcare professiona15 and referrer5, and creates a cohesive and professional identity for use across all communications and fundralsing materials. Feedback indicates that the name re50nates strongly wlth both professional audiences and the wider community, providing immediate clarlty about who we are and what WÈ do.

THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER2025 The Tru5tee5 are confident that these changes posltion The Neuro Therapy Place for a strong and sustainable future. While our name and structure have evolved, our mission remains unchanged, to deliver high quality neurological and oxygen therapy in a eornpa55ionate, community focused environment. These developments ensure that we are better equipped to grow our reach, strengthen partnership5, and continue supporting people living with neurological condition5 across Scotland. Impact of Cost-of-Llvlng Crlsls The cost-of-living crisis has continued to make the working environment increasingly difficult, wlth operational cost5 continuing to rise. At the same time, our donors and supporters are experiencing higher bills and reduced real income5, lirniting their capacity to contribute at previous levels. With numerous charities now vying for a smaller pool of funding, we have needed to be more diligent than ever in managing our finances and budgets. Assessin8 Rlsk and Resilience Over the past few years of unprecedented trading conditions, the Board of Trustee5 and staff team have demonstrated remarkable resilience, adapting swiftly, managing rlsks and flnan¢e5 effectively, embracing new ways of working, and conslstently planning carefully for the future. A strong 8overnan¢e framework The Board of Trustees, along with a dedicated staff team have worked hard to provide good strong leadership with a clear strategic direction. Wlth a raft of cost pressures due to inflation from 2023 onwards, the charlty malntained all Its therapie5 and support servlces and has been proactive in using new technologies to help it maintain and sustaln Its servlce provision. During the yearThe Neuro Therapy Place has achieved its broad strategic objective5 and alms: Develop strategic and productive alliances to intrea5e our influence and ability to act. Build financial and staff stability to increase our Smpart, services, and client outcomes ACHIEVEMENTS AND PERFORMANCE Durlng the last year The Neuro Therapy Place has: Had a full overview of our data and communication infrastructure- dlgital processes anil 5yStem5, and are plannlng to Smprove client online experience, data management and data security. Successfully recruited for and hired a fixed term Community Fundraiser and Buslness Development Manager. Reviewed all policles and procedures, increasing benefits to the staff team. Reviewed and built on our health and safety systems. Streamlined our processes to ensure our services are sustainable. Secured core funding to support investment in Services and Service development. Continued offering our rehabilitation service based on new innovatlve rehabilltation technology and equipment,. Alter G treadmill, Molli Suit and G Move Suit. Held multiple open day5 to external partners and healthcare provlders, showta5ing our equipment, servlces and how we support the community. Developed new marketing strategyi Including bullding a new website and recreating our brand identitv. Maintained Real Living Wage accredltatlon. Maintained services, our values and our purpose. Minimised the financlal rlsk to the organisation.

THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OFTRUWEES FOR THEYEAR ENDED 31 DECEMBER 2025 RefininB Howwe Measure Our Impart During the course of this year, we undertook a comprehensive review of our client data and reporting5yStems. As a result, we implemented more robust systems to Improve the 3¢curacy and eonsistenLy of data collection going fonhfard. These lrnprovements provlde a stronger foundation for monitoring our impact and planning for the future. Performance: The Charity delivered a total of 8,076 attendances across a total of 2,610 oxygen, physlotherapy, physiotherapy classes and complementary therapy appointments. We sUPPOrted a total of 433 Clients. The Charity welcomed: a total of 287 new clients. 2025 Total Oxygen Se55ion5 2025 Total Physlotherapyl Rehabllitatlon Se55ions 1,121 2025 Total Physiotherapy Cla55e5 2025 Total Complementary Theraple5 2025 Total Client Numbers 2025 Total New Cllents I,ogi 94 314 433 287 J(

THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 2r.25 T￿lo￿,y.A4IerbYanL¥ F b)J.'CS &*.. Thls reductlon of 346 appolntments and 1,245 booklngs can be attrlbLrted to several factors: Reduction In phy510therapy staff frorn 3 to I, with a staff change in August 2025. This ¢hange reflects Service demand and utilisation levels. The three physiotherapy roles were not operating at full capacity, and there was Insufficlent cllent demand to justify maintaining all three positions. Consolidating to one physlotherapist has reduced Staffing c05t5 while aligning provision more closely with artual need, ￿mproVIng efficiency without comproTllising access to appropriately scheduled care. Proactive suspension of oxygen sessions that did not meet minimum volume requlrements Iminimurn 2 client51. In 2024, solo clients had staff or volunteer support to meet safety pararneters- this is no longer policy as it is not cost effective. Moving to a mSnlmum threshold ensures that staffing and operatlonal costs are proportlonate to the number of clients attending. This change reduces unnecessary staffing expenditure while maintaining safe delivery Standards. More proartive documentation of cancellations for physSotherapy. Improved tratking and documentation of cancellations has enabled more effective backfilling of appointments. This has increased utilisation of available slots, reduced lost clinical time. and maximised Income 8eneration from existing capacity without requiring additional stafflng. Reduced and compacted available slots for oxygen services. Oxygen se55ions have been streamlined into fewer, more concentrated time slots. While this has resulted in a redurtlon in the total number of sessions delivered, it has increased the average number of clients per session. This is particularly Smportant given rising energy cost5, ensuring that each sesslon Is flnancially viable and that resources are used more efficiently. Significant turnover in eomplementary therapy services, leading to reduced availability and client engagement.

THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 The Therapy Support Fund and Minimum Contribution System The Therapy Support Fund IT5FI, established in 2017, operates to provide a subsidy on the cost of deliveTing our therapies through our minimum contrlbutbon scheme, and provides, where possible, additlonal support for those receiving mean5 tested benefits. TSF helps in reducing the financial burden for people livlng Wlth neurologlcal condltions. The TSF provides a 50% subsidy on phy510therapy costs, and 20% on oxygen therapv and group classes costs. This help5 provide client5 Wlth full and continuing access to all the charity's therapies and servlces. Funds raised through community fundraising activities, donations and grants from award glvlng bodies maintain The Fund. Fundra15ing The Charity would like to take this opportunity to thank all its members, clients. friends, and local Eroups for their support. The charlty is extremely grateful for the support received from trust and foundation5 in 5UPPOrt of the development the charity and its services.. Garfield Weston Foundation, Lady Marian Gibson Charitable TrLJSt, james T Howat Charitable Trust, Tillyloss Trust, Henderson Loggie Charitable Trust, Rotary Club of Edinburgh Jubilee Fund, Walter Scott & Partners Giving Group, Lodge of Journeymen Masons No.8. Ward Family Charitable Trust, Charities Aid Foundation Building Resilience Fund, Hospbtal Saturday Fund, The February Foundation, RS Macdonald Charitable Trust, National Lottery Communlty Fund (improving Lives Programmel, Agnes Hunter Charitable Trust, Walker-shoolbraid Charitable Trust, J Smart & Co, Ann Rylands Srnall Donètions (Sir Jules Thorn Charitable Trust), Lothian Buses Ernployees Charitable Fund, The Batchworth Trust, PF Charitable Trust and Eldon Charitable Trust. Rlsk Management The Board of Trustee5 regularly undertakes a revSew of the rlsks to whlch the Charity is exposed, particularly business, operational and financial risks. The Charity has introduced procedure5 and reporting reglmes to mitigate and manage risks. Internal control systems are desiEned to meet the Charity's operatlng needs, the risks to which It Is exposed and to provide reasonable assurance agalnst mlsstatement or loss. The Charity ensures disclosure checks are carried out on all new staff and volunteers, and the Health and Safety policy outlines procedures to ensure compliance with health and safety of staff, volunteers. client5, and vi51tors to the centre. Internal control risks are minimised by the implementation of procedures for authorisation of all transactions and projects. Other policie5 are in place ¢overlng the Protection of Vulnerable Adults, GDPR-data protection. complaints, confidentiality, handlln8 and retention of disclosure information, volunteering, and equal opportunities. The Charity operates regular procedures to monitor the receipt of income and both revenue and capital expendlture, Future Plans The Board welcomes the fresh ideas and enthusiasm demonstrated by our Trustees, volunteers, members, and staff team. The ongoing cost-of-living cri515 and wlder econom1c challenges continue to shape the charity's strategic priorities for 2026 and the following three years. Our key strategic objective for 2026 is resilience. Our alm is to strengthen The Neuro Therapy Place's v1sibility, credlblllty, and reach. We will do this by embeddlng our rebrand, improving our data and operatlonal systems, and developing partnerships that increase awareness of, and acces5 to, our services. Our three-year strategic plan focu5e5 on building a resillent and sustalnable organlsation that maximises outcomes and Impact. To achieve this. we will continue to build on our learnlng and achievement5, diversify income streams, and widen access to our 5ervice5. l. Bylld a flnanclally sustalnable organisation with systems that are flt for purpose. We wlll modernise and streamline our internal systems to strengthen our financial sustainability and reduce operational uncertainty. By improving data management, reducing manual processes, and enhancing the accuracy of financial and servlce delivery records, we aim to free up organisational

THE NEURO THEFiAPY PLACE ANNUAL REPORT OFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 capacity SO that rnore time and energy can be focused on dellvering our mission and supporting clients. We will invest in creating SOP'S that will ensure continuity regarding processes where possible. 2. Strengthen operatlonal effectlveness through Improved Infrastructure and processes. We will review and update our organisational infrastructure to ensure that our systems, policies, and processes support efficient service delivery. This includes investing in too15 and prattices that improve workflow, Increase data reliability, support staff effectiveness, and enable us to monitor outcomes more effettively In a streamlined manner. 3. Bulld and deepen strategic partner5hlps to Increase our reach. influen¢e. and impart. Through our rebrand, targeted marketing, and newly strengthened busine55 development, fundraising, and operational roles led by the CEO, we will Brow external relationships, expand referral pathways, and enhance our ability to respond strateglcally to the wider environment. This wlll increase awarene55 of what we offer and expand our client base. 4. Lead a ¢oheslve transition to The Neuro Therapy Place to strengthen our Identlty and future dlrèctlon. We wi51 Implement our rebrand in 3 clear and consistent way acros5 all communlcations, services, and internal processes. This transition will reinforce our specialist focu5, increase recognlsabi1Stytr and build trust with clients, partner5, and funilers, ensuring a unified organisational Identlty that supports long term growth. Financlal Revlew Total income for the year wa5 £380,98012024.' £350,658). A breakdown of the main categories of income 15 shown overleaf. Fundraising 5%,. Donations; 13% Grant5/Awards 27%,- Services/Therapies'. 54%; Other income Income 2025 and 2024 soy. Sen.']cesnliera￿1.tss 54% 59% fjra.ntslA" 3rds 27Y• 19/0 Dcrnari-. Fur.¢rai>po ￿ 6¥ OiJ)er o, 2025 ll 2024

THE NEURO THERAPY PLACE ANNUAL REPORT OFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 Following a significant drop In 2024, Grants / Awards income has recovered in 2025, up by £37,000155%1. The principal grant funders were Garfield Weston Trust1£30,0001,' Charities Aid Foundation 1£20,0001,. National Lottery Community Fund 1£18,4341 and RS MacDonald Charitable Trust 1£18,4341. Although lower in percentage terms, income from service51 therapie5 in 2025 wa5 only marginally lower at £204,000 in 2025 v £206,000 in 2024. Donations and Fundraising were a150 lower in 2025. down by £7,000 and £3,000 respectively. Total expenditure for the year wa5 £359,65312024: £468,762) of which 54%12024.' 64%) was staff costs and 46%12024.' 36%) was non-staff costs. The reduced staff expenditure principally refletted the restructuring at the end of 2024. Expenditure in 2025 and 2024 4￿.4 Stnfl 64% Noy-staff 36% 2025 u2024 The net result for the year was a surplus of £21,327. Reserves Poli¢y A portlon of the reserves Is deslgnated for emergency or planned expendlture. The Board of Trustees considers that 3-6 months of operatlng costs Is an approprlate level of general funds to maintain under normal operations. With the current cost of living ¢rislS these funds are being carefully monitored and 8eneral funds supplemented where posslble through grants and government aid programmes to ensure the Charity can sustain service delivery dudng these challenging tlmes. At the end of 2025 restrirted funds stood at £13,35812024'. £29,706). Unrestrltted funds stood at £231,957 12024: £194,282), of which £125,000 Is designated for emergency and urgent B3ro¢hamber repair, improvement, or replacement. The Charl￿5 Costs are currently in the region of £30,WO per month of which some £17,000 relates to salaries and pen5ion5. The general funds at 31 December 2025, were £106,957 which represents a reserve of around 3.5 months running costs. This is at the lower end of the level of general funds that the Board considers appropriate but an improvement on the previous year. However, the 51tu3tion will Continue to be c105ely monitored in 2026.

THE NEURO THERAPY PLACE ANNUAL REPORT OFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 Reference and admlni5trative details Charlty Name The Neuro Therapy Place Formerly- Compass Therapy Support Communlty Limited Charlty Number SC014991 Reglstered offlce & Operatlonal Addre55 Unit 40c Swanfield Edinburgh EH6 5RX Independent Examlner Kevin Cattanach CA Whitelaw Wells Chartered Accountants 9 Ainslie Pla Edinburgh EH3 6AT Bankers The Royal Bank of Scotland 2 Bernard Street Edinburgh EH6 6PU Shawbrook Bank Limited Lutea House Warley Hill Business Park Brentwood Essex CM13 3BE Board of Trustees Charlotte Eldon, Chair Danlel Baigrie, Vice Chair Carole Macartney, Secretary (resigned 13 May 20251 Jarne5 Richardson, Treasurer Louise Murray Ruth Saunders Clalre Maclalne Company Secretsry Ruth Saunder5 Chlef ExecutSve Officer Genevieve Harrison

THE NEURO THERAPY PLACE ANNUAL REPORT OF THE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 20Z5 Structure, Governance and Mana8ement Governlng Document The organisation is a SCIO, incorporated on 5 Novernber 2025, having converted from a charitable company limited by guarantee. When the orEanlsation converted to a SCIO its legal name also became The Neuro Therapy Place. Previously. the organisation was a charitable company lirnited by guarantee having the registered name Compass Therapy Support Community Limited. As part of the conversion to 8 SCIO. the members of the charity adopted a new constitution. The terms of the new constitution establish the objects and powers of the charity and reflect the objects and powers of the Articles of Association that previously governed the charity when it was a charitable company limited by guarantae. The conversion to a SCIO and adoption of th8 new constitution was undertaken in full consultation with the mernbers and complying withthe regulations as s8t out by the Off ice of the Scottish Charity Regulator. The structure of the organisation consists of.. the members who have the right to participate in members. meetings (including 8ny annual members. m8etingi and have Important powers under the constitution,. for ex8mple. the members elect people to seNe on the board and take decisions on changes to the constitutlon itself., and the Board - who hold regular meetings, and generally control the aetivitles of the org8nisation' for example, the board is responsible for monitoring and controlling the fln8nci81 position of the org8nisBtion. The members of the organisetion have no liability to pay 8ny sums to help to rn88t the debts lor othèr liabilities) of the organisation if it is wound up- accordingly, if the organisation is unable to meet its debts, the members will not be held responsible. Recrultment and Appolntment of Board of Trustees The member5 of the SCIO consist of persons with a medical condition whlch may benefit from the therapies provided or an Interest in promotlng the objects of the organisation as admitted to membership by the Board of Trustees. The Board of Trustees Ss selected from the members of the SCIO and external advert15ing. The members of the Board of Trustees are Charity trustees for the purposes of charity law. The Board of Trustee5 seeks to ensure that the needs of people with neurological conditions are appropriately reflected through the diversity of the trustee body. with a mix of mernbers with neurological conditions and those who, though not themselves, diagnosed with neurological condition have an interest In the aims of the Charity, and can offer approprlate business, clinical or other relevant skills. All members. apart from employees, are eligible to become members of the Board. Trustee Inductlon and Tralnin8 Many new Trustee5 are already famlllar with the practlcal work of the Charity havlng either used the fatilities or volunteered to help in the operation of the Centre prSor to taking up a Trustee role. New Trustees are invited and encouraged to attend a series of short briefing sessions to familiarise themselves with the Charity and the context wlthin which it operates. These are led by the Chair of the Board of Trustees and the Chief Executive Officer and will cover.. The obli8atlons of Board of Trustees members. io

THE NEURO THERAPY PLACE ANNUAL REPORTOFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 The main documents which set out the operational framework for the Charlty Including the Constitution. Resourcing and the current financial position as set out in the latest published accounts. Future plans and objectives. Information is provided drawing from the various Ch8rSty Regulator publication5, and this wlll be distributed to all new Trustees along with the Constitution and the latest financial statements. Trustees are encouraged to attend appropriate trainlng events and any notes from these are circulated to other Trustees to ensure the key learning points are shared. Or8an15atlonal Structure The Charity has a Board of Trustees of up to 11 rnembers who meet every three month5, on a formal ba51S. Trustees will be Invited to contribute thelr skills and expertise in agreed sub-groups for certaln project5. In addition, the office bearers communicate Te8ularlyforthe purposes of taking forward speciflc work areas. The Board of Trustees is responsible for the strategic dirertion and policy of the Charity. A scheme of delegation is in place. Day-to-day responsibility for the provision of the seNices rests with the Chief Executive Officer, who oversees operational management of the Centre and Individual supervision of the staff team, carrles out fundraising activities, and ensures that the team contlnues to develop their skllls and working practlces in line with good prèctlce. The Board of Trustees would Ilke to acknowledge the continued and valued contrlbutlon to the smooth running of the centre fr()m its dedicated group of volunteers. Volunteers contribute to all aspects of service deliveryfrom supporting the operation of the oxygen chamber, essential maintenance and repair and cleaning and hygiene input. The Board of Trustee5 15 also acting In a voluntary role and make considerable input to the direction of the Centre. In 2025 volunteer time contrlbution amounted to the equlvalent of some £83,575.23. This can be broken down to £32,191.23 operational volunteer time and £51,384 Tru5tee5' input. As of December 2025, there were 22 active volunteers, excluding 6 Tru5tee5. Related Partles In 50 far as it is complernentary to the Charl￿5 objects, the Charltyls guided by both lotal and national policy. The Charity is a rnemberof the Neuro Therapy Network INTNI, formerly MS National Therapy Centres IMSNTCI an umbrella Charity registered in England and Wales and In Scotland. As a member of NTN, the Charity benefits from the provision of national standards for the delivery of oxygen therapy. NTN holds Open Meetings around the UK to enable Centres to communicate and share ideas and best prattlce. The representation of other Centres wlthin this group has proved invaluable to the Charity in establlshlng Improved links within the MS community and identifying relevant policy developments and prospective treatment5 and how they may be funded. The charity 15 also an actlve member of.. The Alliance- The Health and Social Care Alliance Scotland,. The Neurological Alliance,. Voluntary Health Scotland.. Self-Direeted Support Scotland; Scottish Councll of Voluntary Organisations; Edinburgh Council for Voluntary Organi5ations. RESPONSIBIUTIES OFTHE BOARD OF TRUSTEES The Charity Trustees are responsible for preparing a dlrectors, annual report and flnanclal statement5 in accordance with appllcable law and United Kingdom Accounting Standard5 Iunlted Kingdom Generally Accepted Accounting Practice). The law applicable to charltles In Scotland require5 the Trustees to prepare financial statements for each year which give a true and fair view of the State of affalrs of the charity and of the Incomlng resources and

THE NEURO THEFiAPY PLACE ANNUAL REPORTOFTHE BOARD OF TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025 application of resouTces of the charity for that year. In preparing the flnancial statements, the Trustees are required to.. selett sultable accounting policies and then apply them consIstentlv,' observe the method5 and principles in the Charities SORP; make judgements and estimate5 that are reasonable and prudent,. state whether applicable UK accounting standards have been followed, Subject to any material departures disclosed and explained in the financial statements; prepare the flnancial statements on the going concern basls unless it 15 inappropriate to presume that the Charity will contlnue in operation. The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial posltion of the Charity and to enable them to ensure that the financial statements comply with the Charities and Trustee Investment Iscotlandl Act 2005, the Charities Accounts Iscotlandl Regulations 2006 las amended) and the provisions of the charity's constitution. They are also responsible for safeguarding the assets of the Charity and hence taking reasonable steps for the preventlon and detection of fraud and other irregularities. The Trustees are responsible for the maintenance and Sntegrity of the corporate and financial Information included on the charittys website. Legislation in the United Klngdom governing the preparation and dissemination of financial statements may dlffer from legislation in otherjurisdictlons. Signed by order of the Board of Trustees: Charlotte Eldon Trusteelchalr James Richard50n Trusteerfrea5urer Registered office.. Unit 40C, Swanfield EdinburEh EH6 5RX Approved by the Board of Trustees on 16, June 2026 12

THE NEURO THERAPY PLACE INDEPENDENT EXAMINER'S REPORTTO THE TRUSTEES OFTHE NEUROTHERAPY PLACE FOR THE YEAR ENDED 31 DECEMBER 2025 I report on the accounts of the Charity for the year ended 31 December 2025 whith are Set out on pages 14 to 32. Respective Responsibilities of Trustees and Examlner The Charity Trustees are responsible for the preparation of the accounts in accordance with the temis of the Charity and Trustee Investment Iscotlandl Act 2005 and the Charitie5 Account$1Scotlandl Re8ulations 2006 las amendedl. The Charity's Trustees consider that the audit reqLJirement of Regulation 10111 lal to Icl of the Charities Account5 Iscotlandl Regulations 2006 las amended) does not apply. It is my responsibility to exarnine the accounts as required under sertion 4411) Icl of the Att and to state whether partScular matters have come to my attention. Basis of independent examinerfs statement My examination is carried out in accordance with Regulation 11 of the Charities Accounts Iscotlandl Regulations 2006 las amended). An examination includes a review of the accounting records kept by the Charity and a comparison of the accounts presented with those records. It also include5 consideration of any unusual items or disclosures in the accounts and Seeks explanations from the trustees concerning any such rnatters. The procedures undertaken do not provide all the evidence that would be required in an audlt, and consequently I do not expre55 an audit oplnion on the view given by the accounts. Independent examinerfs ststement In the course of my exarnination, no matter has come to my attention- which Elves me reasonable cause to believe that in any material respect the requirements.. to keep accountlng record5 in accordance with Sertion 441lllal of the 2005 Act, Regulation 4 of the 2006 Accounts Regulations las amended); and to prepare accounts which accord wlth the accounting record5 and comply wlth Regulation 8 of the 2006 Account5 Regulations la5 amendedl have not been met, or to which, in my opinion, attentlon should be drawn In Order to enable a proper under5tandlng of the accounts to be reached. Name.. Kevin Cattanach Relevant Professional Qualification.. Chartered Accountant IICASI On behalf of Whitelaw Wells 9 Alnslie Place Edlnburgh, EH3 6AT Date.. 16, June 2026 13

THE NEURO THERAPY PLACE INCOME AND EXPENDITURE ACCOUNT INCORPORATING THE STATEMENTOF FINANCIALAcfiviTIES YEAR ENDED 31 DECEMBER 2025 Note Unrestricted Restricted 2025 2024 INCOME Income and endowments from: Donations and legacies Charitable activitie5 Other trading activities Investments Other income 48,947 253,380 17,873 2.752 3,900 48.947 307,508 17,873 2,752 3,900 55,497 273,199 21,153 809 54,128 TOTAL INCOME 326,852 54,128 380,980 350,658 EXPENDITURE Expèndlture on: RaisinE funds Charitable activitie5 25,311 263,866 25,311 334,342 32,607 436,155 70,476 TOTAL EXPENDITURE 289,177 70,476 359,653 468,762 NET IEXPENDITUREIIINCOME FOR THE YEAR BEFORETIiANSFERS 37,675 116,3481 21,327 1118,1041 Transfers 18,19 NET MOVEMENT IN FUNDS 37,675 116,3481 21,327 1118,1041 Reconciliation of Funds., Balances brought forward at l January 2025 194,282 29,706 223,988 342,092 Balances carried forward at 31 December 2025 231,957 13,358 245,315 223,988 The Charlty has no recognised gains or105ses other than the results for the year a5 set out above. All of the actlvltSes of the Charlty are classed as continuing. The notes on page5 19 to 32 form part of these flnanclal statements. 14

THE NEURO THERAPY PLACE BALANCE SHEEr AS AT 31 DECEMBER ZOZ5 202S 2024 Note FIXED ASSETS Tangible assets li 62.690 109,627 CURRENT ASSETS Stock Debtors Cash at bank and in hand 1,751 12,178 205,311 2,090 6.796 150.459 12 219,240 116,3431 159.345 119.0791 CREDITORS: amounts lallin8 due wlthin one year 13 NET CUARENT ASSETS 202.897 140.266 TOTAL ASSETS LESS CURRENT LIABILITIES 265,587 249,893 CREDITORS Amounts fallin8 due after More than one year 14 120,2721 125,9051 NET A￿ETs 245,315 223,988 FUNDS Unresrricted.. Designated funds General funds 18 18 125,000 106.957 125.000 69,282 231,957 194,282 RestrScted Funds 19 13,358 29,706 245,315 223,988 The financlal statements were approved bythe Board of Trustee5 on 16 June 2026, and are slgned on their behalf bv.. Charlotte Eldon james Richardson 15

THE NEURO THERAPY PLACE STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2025 2025 2024 Note Cash flows from operating activities: IDecreaselllncrea5e in cash from operating activities 58,317 168.1931 Cash flows from investlnE actlvltles: Interest received Purchase of tangible fixed assets Proceeds from disposal of a55ets 2,752 809 119,2061 1,735 Net cash used in Investlng actlvltle5 2,752 116,6621 Cash flows from financing activities.. Repayments of borrowings 16.2171 16,2161 Net Cash lused inl financin8 actSvlties 16,2171 16.2161 IDecreasel/ln¢rease In cash and cash equivalents in the year 54,852 191,0711 Cash and cash equivalent5 at the beglnning of the year 150,459 241,530 Cash and cash equivalents at the end of the year Z05,311 150,459 16

THE NEURO THERAPY PLACE NOTESTO THE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 ACCOUNTING POLICIES The principal accounting policies adopted, Judgements and key sources of estlmation uncertainty In the preparation of the flnancial statements are as follows.. Basls of a¢countlng The accounts have been prepared In accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charlties preparing their accounts in accordance wlth the Flnancial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021 (effective I January 20191- Charities SORP IFRS1021, the Financial Reporting Standard applicable In the UK and Republlc of Ireland IFR51021. The Neuro Therapy Place meets the definition of a public beneflt entity under FR5102. Assets and liabilities are initially recognised at historical cost or transaction value unless stated in the relevant accounting pollcv notelsl. Le8al Status Note The charity converted from a company limited by guarantee to a Scottish Charltable Incorporated Organisatlon I"SCIO"l on 5 November 2025 in accordance with the Charltles and Trustee Investment IScot5andl Art 2005. Prior to conversion, the Charity operated under the name Compass Therapy Support Community Ltd and was registered with Companles House under company number SC122837 and with the Office of the Scottish Charity Regulator I"0SCR"l under charity number SC014991. On conversion, all assets, liabilities, rights and obligatlons of the former charitable company transferred automatically to the SCIO by operation of law and the charltable activities continued wlthin the SCIO structure without interruption. The charity now operates as The Neuro Therapy Place, Scottish Charity Number SC014991. The trustees consider the conversion to represent a continuation of the same charitable undertaking and accordingly the flnancial statements have been prepared on a golng concern ba515 reflecting continuity of operatlons. Comparative figures for the prior year relate to the former charitable company. Preparatlon of the accounts on a goln8 concern basls At the time of approving the accounts, the Tru5tees' have reviewed the future funding and attlvities of the Charity including current economic uncertainties and inflationary pressure5. The Trustees, have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future and for a period of at least 12 month5 from the date of approval of these financial statements. Thus the Charlty continues to adopt the going concern basis of accountin8 In preparlng the accounts. Income All income is included in the Statement of Financial Activitie5 when the Charity is entltled to the Sncome and the amount can be quantifled with reasonable accuracy. Thefollowing specific policies are applied to particular categories of income- Income from donatlon5 and legacies Include5 all income that is in substance a gift, made to the Charity on a voluntary basis. Thls is included in full in the Statement of Financlal Activities when receivable. Membership income and gifts in kind are included when received. Gifts in kind are valued at a price the 17

THE NEUROTHERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 Charity would have to pay in the open market for the equivalent item. Grants of a general nature, where entitlement is not conditional on delivery of a specified level of service, are recognised when the Charity becomes unconditionally entitled tothe grant. A legacy, in whole or part, is only considered probable when the amount can be measured reliably, and the Charity has been notified of the executols intention to make distribution. Where legacies have been notified to the Charity, or the Charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy Is treated as contingent asset and di5tlosed if m3teria5. Income from charitable attivities includes fees for treatment theraples and income earned both from the supply of services under contrartual arrangements and from performance-related grants which have conditions that Specify the provislon of particular services to be provided by the Charity. Grants where related to performance and specific deliver2ble5, are accounted for as the Charity earns the rlght to tonsideration by its performance. Income from other tradlng activities Includes income earned from both trading activities in order to raise funds for the Charity and income from fundraising events and is recognlsed when receivab5e. Investment income is included when receivable. Expenditure All expenditure is Included on an accruals basis and Is recognised when there Is a legal or constructive obligation to pay. All costs have been direttly attributed to one of the funttional categories of resources expended In the Statement of Financial Actlvlties. The Charitv 15 not registered for VAT and accordingly expenditure Is shown 8ross of irrecoverable VAT. Expenditure on raising funds includes all expenditure incurred by a Charity to raise funds for its charitable purposes. It includes the costs of all fundraising attivities and events and the sale of bought in goods. Charrtable expenditure cornprlses those costs incurred by the Charity in the delivery of its attivitles and services for its beneficiaries. It includes both costs that can be direttly attributed to such activities and those of an indirect nature necessary to support them Including Costs related to the governance of the Charitv. The value of services provSded by volunteers has not been Included in these accounts a5 the monetary value is not easily measured. Support costs are those funciions that asslst the work of the CharSty but do not directly undertake charitable activities. Support costs include finance, personnel, payroll and governance costs which support the Charitvs activities. The bases on whlch support costs have been allocated are set out in note 9. Stocks Stocks are valued at the lower of cost and net reallsable value. Tangible FSxed Assets A55ets are initially included at C05t. Depreciatlon is calculated 50 as to write off the cost of an asset, less Its estimated residual value, over the useful economlc life of that asset as follow5: Equipment Fixtures & fittlngs Property improvements 20% straight1Sne 20% straight line 20% straight line The Charity Capltalises Items above £SOO. 18

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 De51gnated Funds Designated funds are unrestritted fund5 designated by the Board of Trustee5 for a specific purpose. Unrestrirted Funds Unrestricted funds are grants and other Income receivable or generated for the objett5 of the Charity wlthout further specified purpose and are available as general funds. Re5trlrted Funds Restricted funds are to be used for specific purposes as laid down by the donor. Operating lease agreements Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against income on a strai8ht-line basis over the period of the lease. Penslons The Charity operates a deflned contribution pension scheme for all employees who have opted to participate. The assets of the schemes are held separately from those of the Charity in an independently administered fund. Barochamber The costs of the Barochamber were written off to the income and expenditure account in the year of purchase. Merger Accountlng These financials statements have been prepared using merger accounting, in accordance with the Charities Statement of Recommended Practice ISORPI. Mergèr accounting Involves aggregating the a55ets, liabilitie5 and funds of the comblning charities and presentlng them as though they had alway5 been part of the same reporting charity. Although the merger may have taken place part way through a reporting period, the financial statements must be drawn up to include the results of the combining Charitles for the whole reporting period in which the merger occurred. Charitie5 can use merged account5 if.. The beneficiarie5 of the charity have not changed slgnSflcantly,' The purposes for which fLJnds are held have not changed significantly; and The charity Trustees have not changed signiflcantly 2. INCOME FROM DONATIONS AND LEGACIES 2025 2024 Donations Legacies Gift Aid 40,544 6,510 1,893 53,988 1,509 48,947 55,497 Income from donations and legacies was £48,947 12024.. £55,497) of which £48,497 12024.. £51,6471 was unrestricted and £nil12024: £3,850) was restritted. 19

THE NEUROTHERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 3. INCOME FROM OTHER TRADING ACTIVITIES 2025 2024 Fundralslng- event5 Other fundraising Merchandise & refreshment sale5 1,674 12,383 3,816 984 17,616 2,553 17,873 21,153 Income from other trading activltles was £17,873 12024.. £21,153) of which £17,873 12024: £21,513) was unrestricted and £nil12024.. £nlll was restricted. 4. INCOME FROM CHARITABLE ACTIVITIES Llnrestrlcterl Restrlrted 2025 2024 Oxygen Treatment Physiotherapy Other therapies Grant5'. Agnes Hunter Charitable Trust Charities Aid Foundation Febru3ry Foundation Garfield Weston Foundation Henderson Lo8gle Charitable Trust Hospital Saturday Fund National Lottery Cornmunity Fund RS MacDonald CEC- Health & Soclal Care Partnership James Wood Bequest Russell Trust 162,690 33,031 8,659 162.690 33,031 8,659 138,249 55,434 13.131 7.260 10,000 7,260 20.000 5,000 30.000 2.000 2,000 18.434 18,434 8.260 iO.ODO 5.000 30,0)0 2,C4)0 2,(K)O 5,000 30,000 2,000 18,434 18,434 9,125 10.000 2,￿0 253,380 54,128 307,508 273,199 Income from charitable activities was £307,50812024.. £273,199) of whlch £253,38012024.. £250,939) was unre5trltted and £54,12812024.. £22,260) w35 restricted. RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW FROM OPERATING ACTIVITIES 2025 2024 Net movement in funds Add back depreclatlon charge IGainl/Loss on disposal of fixed assets Interest received Decreasellincrea5el In stock Decreaselllncreasel in debtors IncTeaselldecTeasel In credStors 21,327 46,937 1118,1041 47,575 11,1971 18091 11091 13901 4,841 12,7521 339 15,3821 12,1521 IDecrè8sel/lncrease in cash from operating activitie5 58,317 168,1931 20

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 6. NET IEXPENTUREIIINCOME FOR THE YEAR Thls Is stated after charglng:" 2025 2024 Inéependent Examinels remuneration.. External Scrutiny Payroll administration 2,520 1,459 46,937 1,920 1,321 47.575 11,1971 Depreclatlon IGainl/Loss on disposal of fixed assets 7. EXPENDITURE CHARITABLE ACTIVITIES Treatment Project Services Costs Rai5in8 Funds 2025 2024 Dlrect costs allocated to actlvltles: Fundraising & marketing Physiotherapy staff costs Inote 101 Physio & other therapy services Beneficiary support costs Equipment maintenance and running costs Support Costs allocated to activities: Other staff costs (note 101 Staff recruitment & training Volunteer & Trustee expenses Purchases Rent, rates, insurance & repairs Heat & light Telephone & IT support Office supplies, post and stationery Travel & subscriptions Independent Examination fee Accountancy support Legal and consulting fees Payroll administration Bank charges & other admin Loan interest Depreciation IGainllL055 on disposal of fixed a55et5 7,017 1,145 44,628 8,162 16,010 77,443 140,153 7,375 5,900 4,000 32,815 7,375 4,000 11,842 244 12,086 10,648 17,354 91,787 2,356 879 7,975 117,116 162,148 2,356 3,102 879 196 940 1,127 30,075 29.990 18,685 18,784 11,158 10,026 2,464 4,014 4,707 4,978 2,520 1,920 5,118 4,830 1,350 2,245 1,459 1,321 4,101 4,135 722 857 46,937 47,575 11,1971 940 30,075 18,685 11,028 2,464 4,707 2,520 5.118 600 1,459 4,101 722 35,333 130 750 11,604 25,311 263,866 70,476 359,653 468,762 Total expenditure was £359,65312024- £468,7621 of which £289,17712024: £424,449) was unrestrlcted and £70,47612024.' £44,313) was restrlcted. 21

THE NEURO THERAPY PLACE NOTES TO THE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 SUMMARY ANALYSIS OF EXPENDITURE AND RELATED INCOME FOR CHARITA8LE ACTIVITIES This table show5 the cost tsf the two main charitable activities and the sources of income directly to support those activitie5- Treatment Servlces Project Activltles TOTAL Costs Contributions for therapy Direct grant support 1263,8661 204,380 49,000 170,4761 1334,3421 204,380 103,128 54,128 Net shortfall of funds from charitable actSvltles 110,4861 116,3481 126,8341 9. ANALYSIS OF GOVERNANCEAND SUPPORTCOSTS The Charity initially identifies the cost5 of its support function5. It then identifies those cost5 which relate to the governance function. Governonce costs and other 5UPPOrt Costs are apportioned separately between the two maln charitable activities undertaken (see note 71 In the year. Refer to the tsble below for the basis for apportlonment and the analysis of support and governance costs. Analysls of Support and Governance Costs General Support Governance Functlon TOTAL Basls of Apportlonment Salarles, wages & related costs Volunteernrustees expenses Premises & office costs Independent examination fee5 Accountancy / other professional fees 111,497 879 108,056 111,497 879 108,056 2,520 7,177 staff time exp, claim Invoiced exp, governance Snvolced exp. 2,520 700 6,477 TOTAL 226,909 3,220 230,129 22

THE NEURO THERAPY PLACE NOTESTOTHE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 10. STAFF COSTS The aggregate staff costs were: 2025 2024 Salaries Reéundancy costs Employers, Nl Pension Staff insurance/Health Plan 183,485 263,859 16,212 15,946 4,421 1,863 6,951 2,957 1,166 194,559 302,301 No employee re￿iVed emoluments totalling more than £60,OW in the year. No trustees received any remuneration or reimbursed expenses in the current or previous year. No trustees received payment for profe55ional or other services Supplied to the Charity12024.' £Nill. The policy for redundancy follows the statutory redundancy provlslons. There were no redundanLy payments outstandlng at the year end. Particular5 of employee5: The average number of staff. calculated on a head count basis, excluding trustees, employed by the Charity during the financial year was.. 2025 No. 2024 No. Senior Management and Administration Physiotherapist5 Project Officers 12 23

THE NEURO THERAPY PLACE NOTES TO THE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 11. TANGIBLE FIXED ASSETS Computer Flxtures & Equlpment Fittln85 Property Improvements Total COST At l January 2025 Additions Disp0531s 6,349 196,752 107,709 310,810 At 31 December 2025 6,349 196,752 107,709 310,810 DEPRECIATION At l January 2025 Charge for the year Released on disposal 4,938 651 114,296 35,019 81,949 11,267 201.183 46,937 At 31 December2025 5,589 149,315 93,216 248,120 NET BOOK VALUE At 31 Docember 2025 760 47,437 14,493 62,690 At 31 December 2024 1,411 82,456 25,760 109,627 12. DEBTORS 2025 2024 Gift aid receivable Prepayments and accrued Income Other debtors 1,624 6,026 4,528 1,535 3,956 1,305 12,178 6,796 13. CREDITORS: amounts falllng due wlthln one year 2025 2024 Bank loans (note 151 Other creditors & accruals 5,633 10,710 5,494 13,585 16,343 19,079 24

THE NEURO THERAPY PLACE NOTESTO THE FINANCIAL5TATEMENTS YEAR ENDED 31 DECEMBER 2025 14. CREDITORS: amounts falling due after more than one year 2025 2024 Bank loans (note 151 20,272 25,905 20,272 25,905 15. BANK LOANS 2025 2024 Due in less than one year Due in one to two years Due in two to five years Due in more than five years 5,633 5,775 14,497 5,494 5,633 17,767 2,505 25,905 31,399 The Charity secured the UK Government backed Bounce Back Loan Sn May 2020. The loan term has been extended to ten years with no payments in the first twelve months and interest covered by the UK Government. The interest rate 15 2.5% fixed for the remaining nine years. 16. ANALYSIS OF CHANGES IN NET DEBT At I" Jan 2025 At 31st Dec 2025 Cash flows Other non- cash changes Cash and cash equlvalents Cash Instant access bank accounts Fixed or notlce term deposlts 164 150,295 164 122,397 82,750 127,8981 82,750 150,459 54,852 205.311 Borrowlngs Debt due wlthln one year Debt due after more than one year 15,4941 125,9051 11391 5,633 15,6331 120,2721 131,3991 5,494 125,9051 25

THE NEURO THERAPY PLACE NOTESTOTHE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 17. COMMITMENTS UNDER OPERATING LEASES At 31 December 2025 the Charity had total commitments under non-cancellable operating lease5 as set out below. Land and bulldlngs 2025 2024 Operatlng leases whlch explre., Within I year Within 2 to 5 years 18,268 3,953 17,289 22,192 22,239 39,481 18. UNRESTRicfED FUNDS Balance at l January 2025 Balance at 31 December 2025 Income Expendlture Transfers Designated Funds.. Barochamber Repair & Improvement fund Therapy support fund 125,CQO 125,000 234,074 1260.6461 26,572 125,000 234,074 1260,6461 26,572 125,000 General funds 69,282 92,778 128,5311 126,5721 106,957 194,282 326,852 1289,1771 231,957 The Barochamber Repair and Improvement fund (formerly the Development Fund) is set up to finance any future major repairs to the chamber system or any future re-location costs of the Centre, or the purchase of new Barochamber should the existing chamber need replacing. The replacement C05t Is antScipated to be in excess of the balance currently held. The Therapy Support Fund has been set up to enable anyone to access the services of the Centre and by 50 doing address health inequalitles by removing financial barriers for those who are unable or find it difficult to pay for the cost of treatment. 26

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 18. UNRE5TRicfED FUNDS Iconvdl The other main funders contributlng to the Therapy Support Fund in 2025 are listed below. Freemasons Harper Macleod LLP JSmart&Co Lothian Buses PF Charitable Trust Rotary Edinburgh Sir Jule5 Thorn Charitable Trust £1,000 £500 £2,244 £450 £3,000 £1,000 £3,500 The Batchworth Trust The Eldon Charitable Trust The Lady Marian Gibson Trust The Walter Scott Giving Group The Ward Charitable Trust Tillyloss Trust Walker Shoolbraid Trust £5,000 £2,500 £2,000 £5,000 £1,500 £1,000 Ei,000 UNRE5TRl￿ED FUNDS- 2024 Balance at Balance at l January 2024 31 December 2024 Income Expendlture Transfers Designated Funds.. Barochamber Repair & Improvement fund Therapy support fund 125,000 125,000 250,233 1389,2421 139,009 125,000 250,233 1389,2421 139,009 125,000 General fund5 165,577 74,315 135,2071 1135,4031 69,282 290,577 324,548 1424,4491 3,606 194,282 27

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 19. RESTRicfED FUNDS Balance at l January 20Z5 Balance at 31 Decèmber 2025 Income Expendlture Transfers Phy510therapy equlpment 999 Adapt & Thrive 14,499 Rehabilitation / Wellbeing Support Online Physio class Equip Fund Physio classes at LVSC Long Covid Support Fund Fatigue & Wellbeing Fund Holst Fund Shockwave Machine Fund Building Resilience 19991 17,5141 136,8681 17151 13781 14,0001 17,7601 12441 11,9981 iio,0001 6,985 36,868 715 757 4,000 500 244 7,992 379 7,260 5,994 10,000 29,706 54,128 170,4761 13,358 Phy510therapy equlpment- Funds received from a number of Trusts and Foundations in 2023 to purchase up to date èqulpment for use in the physiotherapy department including Funrtional Elettric31 Stlmulation IFES) equipment and MOTOMed movement therapy equipment. Funds received from Nancie Massie Charitable Trust, Cotton Trust and Percy Bilton Trust. The net book value of asset5 purchased is now nil. Funding from the Communities & Recovery Fund IAdapt & Thrivel supporting the remodelling and reflttlng of our premlses, expansion of phy510therapy treatment rooms with increased physio equlpment. The remaining balance represents the net book value of assets purchased with these funds. Rehabilitation 2nd Wellbeing Support Servi¢e- Match funding from the National Lottery Community Fund and RS MacDonald for three years to 5UPPOrt people wSth complex neurological conditions. The projert will help people to self-manage, develop coplng strategies and increase Social activities. Online Physlo Class Equipment- funding from various sources to support the purchase of online equipment for services and classes. The net book value of a55ets purchased Is now nil. Funding from the SG Mental Health & Wellbeing Fund Ivia EVOCI to work in partnership with Edinburgh Leisure to dellver physio/exercise classes at Leith Victoria Swim Centre ILVSCI. The remaining balance represents the net book value of equipment purchased for asslstance with patient mobility. Fundlng frorn the Souter Trust and Russell Trust to provlde support fgr clients suffering with Long Covid in accesslng oxygen therapy. Thi5 funding has now been fully utilised. Funding from the Agnes Hunter Trust allowed us to develop and dellver a serles of free fatigue and wellbeing educatlon and sUPPOrt classe5 throughout 2024 and 2025. This Initiative was driven by client feedback, gathered through a survey in which rnany expressed a need forgreater support in managingfatigue and overall wellbeing. In re5pon5e, our physiotherapy and rehabilitation team designed and implemented a 19. 28

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENOED 31 DECEMBER 2025 RESTRICTED FUNDS I￿n￿dI structured programme airned at equipping participant5 With practical strategies to Improve energy management, enhance daily functionin& and promote overall health. Funding from a client user to purchase a new hoist for the Physiotherapy department. The net book value of asset5 purchased 15 now nll. Shockwave Machine Fund.. With funding from the Hospital Saturday Fund and James Wood Bequest, we purchased a Shockwave Therapy Machine for use in the Phy510therapy department. This investment enhantes treatment options, particularly for clients with neurological conditions experiencing spasticity, such as those with stroke, multiple 5clerosis, cerebral palsy, spinal cord injury, and traumatic brain injury. Research shows that focused shockwave therapy can reduce muscle Stiffness, improve range of motion, decrease pain, and enhance functlonal movement. By Integrating this non-lnvasive treatment into our physiotherapy and rehabilitation services, we aim to support better mobility and quality of life for our clients. The balance represents the net book value of the asset. Building Reslllence.. Funding from CAF over two years to undertake work supportlng resilience buildlng within the organisation. RESTRicfED FUNDS- 2024 Balance at l January 2024 Balance at 31 December 2024 Income Expenditure Transfers Physiotherapy equipment 1,998 Adapt & Thrive 22,013 NLCF- Wellbein8 Support Service 22,852 Online Physio class Equlp Fund 1,517 Physio classes at LVSC 1,135 Long Covid Support Fund 2,000 Fatigue & Wellbelng Fund Hoist Fund Shockwave Machine Fund 19991 17,5141 122,8521 18021 13781 999 14,499 715 757 4,0 51)0 244 7,992 2,Ix)O 8,260 3,850 12,000 17,7601 13,6061 14,0081 51,515 26,110 144,3131 13,6061 29,706 29

THE NEURO THERAPY PLACE NOTES TO THE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 20. ANALYSIS OF NET ASSETS BETWEEN FUNDS Unrestricted Restricted Funds Funds 2025 2025 Total Funds 2025 Tangible fixed assets Current assets Ctjrrent liabilltles Long term liabilities 49,332 219,240 116,3431 120,2721 13,358 62,690 219,240 116,3431 120,2721 Net assets 231,957 13,358 245,315 ANALSYSIS OF NET ASS￿5 BEfwEEN FUNDS- 2024 Unrestrlcted Restrlrted Funds Funds 2024 2024 Total Funds 2024 Tangible fixed assets Current a55et5 Current liabilitles Long term liabilities 84,665 154,601 119,0791 125,9051 24,962 4,744 109,627 159,345 119,0791 125,9051 Net assets 194,282 29,706 223,988 30

THE NEURO THERAPY PLACE NOTESTOTHE FINANCIALSTATEMENTS YEAR ENDED 31 DECEMBER 2025 21. DISCLOSURE RELATING TO CHANGE IN LEGALSTATUSTO SCIO- MERGERACCOUNTING NOTE On 5 November 2025, the assets and liabilities of Compass Therapy Support Community Ltd were transferred to The Neuro Therapy Place. In accordance with section 27 of the Charity SORP, the transfer of assets and liabilities has been treated as a merger with all item5 transferred at carrying value and no gain or loss arising. The trustees conslder that the conversion to SCIO status did not alter the underlying charitable activities or operatlDns of the organisation and therefore the comparative figures provide meaningful comparative infoTmation. ANALYSIS OFTHE PRINCIPAL COMPONENTS FOR THE YEAR ENDED 31 DECEMBER 2025 Compass The The Therapy Neuro Neuro Support Therapy Therapy Combined Llmlted Place Pla¢e Total pre-mer8er pre-merger post-merger Total Income Total Expenditure 335,621 1291,6771 45,359 167,9761 380,980 1359,6531 Net Income / Expenditure 44,944 122,6171 21,327 Other G31ns and Losse5 Net Movement in Funds 44,944 122,6171 21,327 ANALYSIS OFTHE PRINCIPAL COMPONENTS FOR THEYEAR ENDED 31 DECEMBER 2024 Cornpass Therapy Support Llmlted The Neuro Therapy Comblned Place Total Total Income Total Expenditure 35D,658 1468,7621 350,658 1468,7621 Net Expenditure 1118,1041 1118,1041 Other Galns and Losses Net Movement in Funds 1118,1041 1118,1041

THE NEURO THERAPY PLACE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2025 ANALYSIS OF NET ASSEfsATTHE DATE OFTHE MERGER. 5 NOVEMBER 2025 Compass Therapy Support Llmlted The Neuro Therapy Comblned Place Total Tangible fixed assets Current assets Current liabilities Long term liabilities 70,512 235,736 117,2371 121,0791 70,512 235,736 117,2371 121,0791 Net assets 267,932 267,932 Represented by Unrestricted funds Restricted funds 231,205 36.727 231,205 36,727 Total 267,932 267,932 22. COMPANY LIMITED BY GUARANTEE The members have each agreed to contrlbute £1 In the event of the company being wound up. 23. RELATED PARTY TRANSACTIONS Dlrertors donated and contributed £3,793 12024: £1,5791 to the Charity during the year by way of voluntary donation5 and contributions to services. Other than donations, no dirertor or a person related to a director had any personal interest In any other contratt or transartion entered into by the Charlty during the year. 24. TAXATION The company has charitsble status and is therefore exempt from tax on its charltable income under the provision of section 505 of the Incorne and Corporatlon Tax. 32